Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cipla
Julphar
Merck
US Army
Accenture
QuintilesIMS
Healthtrust
Federal Trade Commission

Generated: June 20, 2018

DrugPatentWatch Database Preview

AMANTADINE HYDROCHLORIDE - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for amantadine hydrochloride and what is the scope of amantadine hydrochloride freedom to operate?

Amantadine hydrochloride
is the generic ingredient in five branded drugs marketed by Adamas Pharma, Actavis Elizabeth, Alembic Pharms Ltd, Bionpharma Inc, Heritage Pharma, Lannett Co Inc, Newgen Pharms Llc, Sandoz, Strides Pharma, Usl Pharma, Watson Labs, Watson Labs Inc, Zydus Pharms Usa Inc, Solvay, Endo Pharms, Cmp Pharma Inc, G And W Labs Inc, Hi Tech Pharma, Mikart, Pharm Assoc, Teva Pharms, Vintage, Wockhardt Bio Ag, Osmotica Pharm, and Jubilant Generics, and is included in thirty-two NDAs. There are sixteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amantadine hydrochloride has forty-seven patent family members in fourteen countries.

There are seven drug master file entries for amantadine hydrochloride. Forty-five suppliers are listed for this compound.
Pharmacology for AMANTADINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for AMANTADINE HYDROCHLORIDE
Synonyms for AMANTADINE HYDROCHLORIDE
(3R,5S,7s)-Adamantan-1-amine hydrochloride
(3s,5s,7s)-adamantan-1-amine hydrochloride
1-Adamantanamin Hydrochlorid
1-Adamantanamine HCl
1-Adamantanamine hydrochloride
1-Adamantanamine hydrochloride; 1-Adamantylamine hydrochloride; 1-Aminoadamantane hydrochloride
1-Adamantanamine, hydrochloride
1-Adamantanaminehydrochloride
1-Adamantylamine hydrochloride
1-aminoada- mantane hydrochloride
1-Aminoadamantane hydrochloride
1-Aminoadamantene hydrochloride
13878-11-0
665-66-7
768-94-5 (Parent)
A 1260
A0588
A3A501
AB0014024
AB1008533
AC-8689
AC1L20JO
ACMC-209nvq
Adamantamine hydrochloride
adamantan-1-amine hydrochloride
adamantan-1-amine;hydrochloride
Adamantanamine HCl
Adamantanamine hydrochloride
adamantanylamine, chloride
Adamantine hydrochloride
adamantyl amine hydrochloride
Adamantylamine hydrochloride
Adamin
Adamine
ADS-5101
ADS-5102
AI3-52211
AK-40714
AKOS015900347
AKOS015951188
Amantadine (hydrochloride)
Amantadine HCl
Amantadine hydrochloride (JP17/USP)
Amantadine hydrochloride (Symmetrel)
Amantadine hydrochloride [USAN:JAN]
Amantadine hydrochloride [USAN:USP:JAN]
Amantadine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Amantadine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Amantadine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Amantan
amantidine hydrochloride
Amazolon
Ambap665-66-7
Aminoadamantane hydrochloride
AN-7740
ANW-35220
AOB5792
BB_SC-2097
BC204764
BIA4305
C07939
CA-1982
CCG-38899
Cerebramed
CHEBI:2619
CHEMBL1255870
CHEMBL1569
CPD001370746
CS-2502
CTK2F3028
D00777
EBD2156754
EC 211-560-2
EINECS 211-560-2
EU-0100004
EXP 105-1
Exp-105-1
F3111-1111
FT-0622248
GP 38026
HMS1920A19
Hofcomant
HY-B0402A
I14-0454
Influenol
J-650095
J-650235
K091
KB-11068
KS-000009I7
KSC353A2R
LP00004
LS-14931
Lysovir
M6Q1EO9TD0
Mantadan
Mantadix
MCULE-2948891352
MFCD00074723
Midantan
Midantane
MLS000028731
MLS002153257
MLS003899199
MolPort-000-692-440
MolPort-003-925-531
MolPort-038-942-500
Mydantane
N04BB01
NC00489
NCGC00093531-01
NCGC00093531-02
NCGC00093531-03
NCGC00093531-04
NCGC00260689-01
NSC 83653
NSC-755860
NSC-83653
NSC755860
NSC83653
Nurelin
Opera_ID_671
OR14311
Pharmakon1600-01500110
PL003185
PubChem6390
Q-200621
RTR-022507
s2451
SAM002554881
SBB003680
SC-06172
SCHEMBL40713
SMR000059204
SMR001370746
SPECTRUM1500110
SR-01000075353
SR-01000075353-1
ST24032190
ST50508424
STR01017
SY012930
Symmetrel
Symmetrel (TN)
TL8004713
Tox21_500004
TR-022507
TRA0093399
Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, hydrochloride
Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, hydrochloride (9CI)
Tricyclo(3.3.1.13,7)decan-1-amine, hydrochloride
Tricyclo[3.3.1.1 3,7]decan-1-amine hydrochloride
Tricyclo[3.3.1.13, hydrochloride
Tricyclo[3.3.1.13,7]decan-1-amine hydrochloride
Tricyclo[3.3.1.13,7]decan-1-amine, hydrochloride
Tricyclodecane
Trivaline
UNII-M6Q1EO9TD0
V2452
Virasol
Viregyt
Virofral
Virosol
WLN: L66 B6 A B- C 1B ITJ BZ &GH
WOLHOYHSEKDWQH-UHFFFAOYSA-N

US Patents and Regulatory Information for AMANTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Newgen Pharms Llc AMANTADINE HYDROCHLORIDE amantadine hydrochloride TABLET;ORAL 207571-001 Jan 31, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wockhardt Bio Ag AMANTADINE HYDROCHLORIDE amantadine hydrochloride SYRUP;ORAL 075060-001 Dec 24, 1998 AA RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Adamas Pharma GOCOVRI amantadine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208944-001 Aug 24, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Osmotica Pharm OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-002 Feb 16, 2018 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for AMANTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Osmotica Pharm OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-002 Feb 16, 2018 ➤ Try a Free Trial ➤ Try a Free Trial
Osmotica Pharm OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-003 Feb 16, 2018 ➤ Try a Free Trial ➤ Try a Free Trial
Osmotica Pharm OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-001 Feb 16, 2018 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for AMANTADINE HYDROCHLORIDE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,987,333 Composition and method for treating neurological disease ➤ Try a Free Trial
9,072,697 Composition and method for treating neurological disease ➤ Try a Free Trial
6,004,582 Multi-layered osmotic device ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Dow
Merck
Moodys
Queensland Health
Cerilliant
Deloitte
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.